BACKGROUND: Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2). METHODS: Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline. RESULTS: Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women. CONCLUSIONS: Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
BACKGROUND: Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2). METHODS: Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline. RESULTS:Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women. CONCLUSIONS: Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
Authors: Antonio de Padua Mansur; Carlos César Montezino Nogueira; Célia M C Strunz; José Mendes Aldrighi; José Antonio F Ramires Journal: Arch Med Res Date: 2005 Sep-Oct Impact factor: 2.235
Authors: Werner Koch; Petra Hoppmann; Arne Pfeufer; Jakob C Mueller; Albert Schömig; Adnan Kastrati Journal: Circulation Date: 2005-10-04 Impact factor: 29.690
Authors: Inga Peter; Amanda M Shearman; Ramachandran S Vasan; Deborah R Zucker; Christopher H Schmid; Serkalem Demissie; L Adrienne Cupples; Jeffrey T Kuvin; Richard H Karas; Michael E Mendelsohn; David E Housman; Emelia J Benjamin Journal: Am J Hypertens Date: 2005-11 Impact factor: 2.689
Authors: Rose C Christian; Peter Y Liu; Sean Harrington; Ming Ruan; Virginia M Miller; Lorraine A Fitzpatrick Journal: J Clin Endocrinol Metab Date: 2006-04-11 Impact factor: 5.958
Authors: Amanda M Shearman; Jackie A Cooper; Paul J Kotwinski; George J Miller; Steve E Humphries; Kristin G Ardlie; Barbara Jordan; Kathryn Irenze; Kathryn L Lunetta; Stephanie C E Schuit; André G Uitterlinden; Huibert A P Pols; Serkalem Demissie; L Adrienne Cupples; Michael E Mendelsohn; Daniel Levy; David E Housman Journal: Circ Res Date: 2006-02-16 Impact factor: 17.367
Authors: Muthuvel Jayachandran; Claudia C Preston; Larry W Hunter; Arshad Jahangir; Whyte G Owen; Kenneth S Korach; Virginia M Miller Journal: Age (Dordr) Date: 2009-11-12
Authors: Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Keith Y Terada; Marc T Goodman Journal: Cancer Causes Control Date: 2008-08-15 Impact factor: 2.506